Try our Advanced Search for more refined results
October 08, 2010
CELGENE CORPORATION v. NATCO PHARMA LIMITED
Case Number:
2:10-cv-05197
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 22, 2015
Celgene Allows Earlier Cancer Drug Generic In Patent Deal
Celgene Corp. has agreed to allow an India-based drugmaker to sell a generic version of its blood cancer treatment in the U.S. more than a year before the last-to-expire patent covering the drug runs out, as part of a settlement the companies reached Tuesday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login